NCT07388524
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07388524
Title Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Acronym AASI-NSCLC Trial
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Kootenai Health - Coeur d'Alene RECRUITING Coeur d'Alene Idaho 83814 United States Details
Kootenai Clinic Cancer Services - Post Falls RECRUITING Post Falls Idaho 83854 United States Details
Kootenai Clinic Cancer Services - Sandpoint RECRUITING Sandpoint Idaho 83864 United States Details
Mercy Hospital RECRUITING Cedar Rapids Iowa 52403 United States Details
Oncology Associates at Mercy Medical Center RECRUITING Cedar Rapids Iowa 52403 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field